Capital World Investors 13D and 13G filings for Quince Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-08 12:56 pm Sale | 2022-07-11 | 13G | Quince Therapeutics, Inc. QNCX | Capital World Investors | 0 0.000% | -2,501,882 (Position Closed) | Filing |
| 2022-02-11 2:48 pm Sale | 2022-02-14 | 13G | Quince Therapeutics, Inc. QNCX | Capital World Investors | 2,501,882 8.400% | -668,849 (-21.09%) | Filing |
| 2021-03-10 2:10 pm Purchase | 2021-03-10 | 13G | Quince Therapeutics, Inc. QNCX | Capital World Investors | 3,170,731 10.700% | 560,494 (+21.47%) | Filing |
| 2021-02-16 12:34 pm Purchase | 2021-02-16 | 13G | Quince Therapeutics, Inc. QNCX | Capital World Investors | 2,610,237 8.800% | 2,610,237 (New Position) | Filing |